Conversely, overexpression of LINC00330 in ESCC can suppress CCL2 expression, block the binding of CCL2 to CCR2 and activate its downstream signaling pathway to a certain extent, ultimately promoting a reduction in ESCC malignancy. This evidence concerns the gene LINC00330 and esophageal squamous cell carcinoma.